8-K - CNS Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On December

Management Change

$580.0K

9.01

. Financial Statements and Exhibits No. Description 10.1 Employment Agreement between Rami Levin and CNS Pharmaceuticals, Inc. dated December 16, 2025 10.2 Sepa

Exhibits Only

Exhibits (3)

10.1

EMPLOYMENT AGREEMENT

10.2

SEPARATION AND SEVERANCE AGREEMENT

8-K

CURRENT REPORT